Akero Therapeutics, Inc. (AKRO) Social Stream
Akero Therapeutics Inc (AKRO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Akero Therapeutics Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 7 | $64 | $27 | $48 | $15.25 | 214.75% |
| 2021-11-15 | 7 | $62 | $27 | $47.714 | $15.25 | 212.88% |
| 2021-12-22 | 7 | $62 | $29 | $47.571 | $15.25 | 211.94% |
| 2022-02-25 | 7 | $62 | $26 | $47.142 | $15.25 | 209.13% |
| 2022-02-28 | 4 | $62 | $26 | $46 | $15.25 | 201.64% |
The Trend in the Analyst Price Target
Over the past 45 weeks, AKRO's average price target has gone down $14.71.
Over the past 47 weeks, AKRO's average upside potential has been 136.64%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-03 | 3 | 81 | 46 | 60.71 | 28.64 | 111.98% |
| 2021-07-17 | 3 | 82 | 46 | 60.86 | 22.33 | 172.55% |
| 2021-08-07 | 8 | 68 | 46 | 57.33 | 20.47 | 180.07% |
| 2021-09-20 | 8 | 65 | 40 | 54.71 | 23.24 | 135.41% |
| 2021-10-19 | 7 | 64 | 27 | 48.00 | 21.45 | 123.78% |
AKRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 26 weeks, AKRO's average broker recommendation rating improved by 0.29.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AKRO as an investment opportunity.
- In the context of all US stocks, Akero Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 713.72% of them.
- AKRO has a lower variance in analysts' estimates than -574.88% of all US stocks.
- In the context of stocks in the small market cap category, Akero Therapeutics Inc's average analyst price target is greater than 687.98% of them.
- In the context of stocks in the small market cap category, Akero Therapeutics Inc's number of analysts covering the stock is higher than 618.47% of them.
In the Pharmaceutical Products industry, AKBA, AGLE, and AFMD are the three stocks most similar to Akero Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Is AKRO a Buy, Hold or Sell? See the POWR Ratings now!